If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
55.00    1.50 (2.80%)
Bid:
54.00
Ask:
56.00
Spread: 2.00 (3.704%)
Market Cap: £105.52m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Market update

11 Apr 2016 07:00

RNS Number : 7163U
Iofina PLC
11 April 2016
 

 

11 April 2016

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Q1 MARKET UPDATE

124.6 metric tonnes of iodine produced from five IOsorb® plants

Production target of 250-270 metric tonnes of iodine in H1 2016

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, today provides an update to the market regarding iodine production in the first quarter of 2016.

 

Iofina produced a total of 124.6 metric tonnes (''MT'') of crystalline iodine in Q1 2016 from its five IOsorb® plants. This compares to 127.9MT of crystalline iodine produced from six plants in Q1 2015 of which over 5.5MT was produced at the now closed IOsorb® IO#1 plant. The net iodine production in Q1 from the Company's Oklahoma operations increased year on year. The Board reaffirms its production target of 250-270MT of crystalline iodine in H1 2016.

 

Historically, Iofina's iodine production during the winter months is generally more challenging due to downtime driven by temperature and weather related issues. Additionally, and since the Company's 18 January 2016 RNS, the Oklahoma Corporation Commission (''OCC'') has implemented additional plans to reduce produced brine volumes injected into the Arbuckle geologic formation in response to seismic activity in an approximately 10000 sq. mile area of North West and central Oklahoma.

 

The Board is pleased to report that Iofina and its partners have been working cooperatively to ensure that the Company's IOsorb® plants, at a minimum, maintain current levels of brine processing and ideally expand volumes to some of our plants. These plans can vary per IOsorb® plant, but generally entail being less associated with a particular Salt Water Disposal injection well (''SWD''), and more so being tied into the producer's main brine pipeline network. The tie in work is anticipated to commence shortly at two of the Company's IOsorb® plants and should require minimal capital expenditure. Even with the OCC restrictions and a slowdown of new well drilling rates in Iofina's core area, there remains an abundance of brine for the Company's current plants and potential future sites. The Company has continued to implement strategies to trim iodine production costs.

 

In Q1 2016, iodine pricing for large volume users of iodine slipped below US$25/kg. Whilst not definitive, the Board has seen recent signs of price stabilisation across the global iodine market. Some indicators to this price indication are supply/demand equilibrium for iodine in conjunction with the recent weakening of the US Dollar versus the Japanese Yen and Chilean Peso. The Company sees less downside risk for iodine prices in the near term.

 

During Q1, Iofina had a hearing with respect to the Company's requested judicial review of the Atlantis Water Solution's water permit. The Company expects to receive a ruling late in Q2 of 2016 for this non-core project.

 

 

 

 

 

 

Commenting, President and CEO Dr. Tom Becker, stated: 

 

"I am pleased by our response to the challenges faced in 2016. Iofina produced more iodine from its Oklahoma operations at a significantly lower cost than the same period in 2015 and is on target to reach H1 production goals. 

 

"The actions the Board is taking, in conjunction with the Company's producing partners, to mitigate future risk and ensure brine supply remain encouraging. We have been pleased with the continued sales of produced iodine to the global market. The Board continues to actively execute its business plan whilst managing the debt position in the current challenging commodities market. " 

 

 

For further information, please contact:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWFASFMSELL
Date   Source Headline
19th Apr 20127:56 amRNSAppointment of Investec as Nomad and Sole Broker
10th Apr 20129:39 amRNSHolding(s) in Company
5th Apr 20128:05 amRNSPurchase of Production Site & Recycling Initiative
2nd Apr 20125:01 pmRNSHolding(s) in Company
29th Mar 201212:11 pmRNSHolding(s) in Company
19th Mar 20127:00 amRNSCorporate Update
25th Nov 20117:00 amRNSDirector/PDMR Shareholding
24th Nov 20117:00 amRNSDirector/PDMR Shareholding
17th Oct 20117:00 amRNSHolding(s) in Company
27th Sep 20117:00 amRNSHalf Yearly Report
9th Aug 20117:00 amRNSTrading Update
30th Jun 20114:42 pmRNSResult of AGM
24th Jun 201111:42 amRNSHolding(s) in Company
8th Jun 20117:00 amRNSAmbrian Partners Appointed Joint Broker to Iofina
7th Jun 20117:00 amRNSIofina Reports Audited Full Year Financials
31st May 20116:03 pmRNSHolding(s) in Company
4th May 20114:32 pmRNSHolding(s) in Company
4th May 20114:29 pmRNSHolding(s) in Company
28th Apr 201112:58 pmRNSHolding(s) in Company
20th Apr 20117:00 amRNSPlacing
13th Apr 20116:28 pmRNSHolding(s) in Company
25th Mar 20117:00 amRNSContract Win
18th Mar 20117:00 amRNSHolding(s) in Company
1st Mar 20113:35 pmRNSHolding(s) in Company
27th Jan 20115:27 pmRNSHolding(s) in Company
12th Jan 20114:40 pmRNSSecond Price Monitoring Extn
12th Jan 20114:35 pmRNSPrice Monitoring Extension
3rd Dec 201012:46 pmRNSOperations Update
19th Oct 20105:30 pmRNSHolding(s) in Company
29th Sep 20109:26 amRNSHolding(s) in Company
28th Sep 20107:01 amRNSInterim Results
28th Sep 20107:00 amRNSAppointment of Finance Director
31st Aug 20107:00 amRNSFourth Extraction and Collection Agreement Signed
16th Jul 20105:57 pmRNSHolding in Company - Replacement
16th Jul 20105:02 pmRNSHoldings in Company
7th Jul 201010:00 amRNSResult of AGM
4th Jun 20107:00 amRNSFinal Results
20th May 20107:00 amRNSNew Agreement Signed and Operations Update
4th May 20107:00 amRNSIssuance of Permit
14th Apr 20107:00 amRNSThird Party Iodine Agreement Signed
22nd Mar 20108:36 amRNSFirst Third Party Iodine Extraction and Collection
22nd Mar 20107:00 amRNSRe Iodine Extraction and Collection Agreement
8th Mar 20107:02 amRNSOperations Update
8th Mar 20107:00 amRNSManagement changes
12th Jan 20103:09 pmRNSDirectorate Change
8th Jan 20107:00 amRNSDirector's Dealings
11th Dec 20096:00 pmRNSHolding in Company
22nd Oct 20095:14 pmRNSChange of Name of Nominated Adviser
19th Oct 20094:07 pmRNSExercise of Options
30th Sep 20097:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.